Upcoming Events
Harbour Biomed 2021 Virtual Investor Forum On Highly Effective Innovation Engine Drives Value Creation
KOL Webinar on Theratechnologies’ SORT1+ Technology™ and TH1902 for Treating Advanced Solid Tumors
Sierra Oncology (SRRA) Myelofibrosis KOL Panel to Highlight Momelotinib Data Presented at ASCO and EHA
BeyondSprings Pharma R&D Day: Novel Immune Agent Plinabulin’s Development Program in Anti-cancer Indications
Taysha Gene Therapies R&D Day 1
Taysha Gene Therapies R&D Day 2
Scynexis BREXAFEMME® (ibrexafungerp tablets) Commercial Launch Update
Corsair Pharma, Inc KOL Webinar on the Treatment of Pulmonary Arterial Hypertension
Clene Inc. Expert Perspectives Webinar on Cellular Energetic Failure: Addressing Unmet Needs and a New Investigational Treatment for ALS and MS
Sequana Medical KOL Webinar on the impact of Refractory or Recurrent Liver Ascites on Patients and Healthcare systems and the potential for alfapump® therapy in NASH-related Ascites
Catalyst Biosciences’ R&D Day: CB 4332 and Proteases in Complement
Celyad Oncology R&D Day Webinar
Noema KOL Webinar On Seizures In TSC
Cortexyme KOL Webinar Series on Atuzaginstat:Part 1: Innovation in Periodontal Disease – A Major Unmet Medical Need
CytoImmune Therapeutics, Inc. KOL Webinar on Human Natural Killer (NK) Cell Immunotherapy
Infinity Pharmaceuticals KOL Event: MARIO-3 TNBC Study Update and MARIO-275 UC Status Update
Taysha GTx Manufacturing Day
M6P Therapeutics KOL Webinar on Lysosomal Storage Disorders
Cortexyme KOL Webinar Series on Atuzaginstat: Part 2: Innovation in Alzheimer’s Disease – Getting to the Root Cause of Neurodegeneration
Tenax Therapeutics KOL Webinar on Levosimendan for Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
Entasis Expert Perspectives on Acinetobacter Infections Webinar
Taysha Gene Therapies: CLN1 KOL Webinar
BrainsWay KOL Webinar on Deep TMS™ Therapy for Treating Mental Health Disorders
Erytech Pharma KOL Webinar
Cardiff Oncology will Present New Data from Lead Clinical Program in KRAS-mutated Colorectal Cancer
Amryt Virtual Capital Markets Event
KOL Webinar on Tesamorelin for the Treatment of Non-Alcoholic Steatohepatitis (NASH)
Cidara Therapeutics R&D Day
UNITY Biotechnology Investor Call With Retinal Expert Dr. Robert Bhisitkul to Discuss New Data From UBX1325
BioDelivery Sciences International Investor Day on ELYXYB for the Acute Treatment of Migraines
BioVie KOL Webinar on Neuroinflammation and Insulin Resistance and New Treatment Approaches for Alzheimer’s Disease (AD)
Sensorion KOL Event on Cisplatin-induced ototoxicity
Immutep Webinar to Discuss Final Overall Survival Data Presentation from the AIPAC Study of Eftilagimod in Metastatic Breast Cancer at SITC 2021
Antengene Research & Development Day
Portage Biotech KOL Webinar on How iNKT Agonists Could Improve Immuno-Oncology
iCAD Inc. Optimizing outcomes and efficiency: iCAD’s world-class solutions for the early detection and treatment of cancer
ProQR Therapeutics Analyst Day
Apexigen KOL Webinar on Post-Anti-PD-(L)1 Melanoma
Dyve Biosciences KOL Webinar on Gout
NOXXON Pharma KOL Webinar on NOX-A12 & Radiotherapy Combination: A Differentiated and Promising New Approach to Treating Brain Cancer
Gain Therapeutics KOL Event on Gaucher and GBA1 Parkinson’s Disease
KAHR KOL Webinar on CD47 Therapeutics: A Potential Treatment For Solid Tumor and Hematological Malignancies
Atai Life Sciences Cognitive Impairment Associated with Schizophrenia: A KOL Webinar
Cardiff Oncology Conference Call and Webcast
DarioHealth (NASDAQ: DRIO) Webinar: Navigating Emerging Digital Health Trends for Strategic Growth in 2022
ASLAN Pharmaceuticals’ A4 webinar series, Aspects of Atopic Dermatitis and ASLAN004
Oncternal Therapeutics Hematological Malignancies and Prostate Cancer KOL Webinar
Motus GI Holdings, Inc. Innovation Day: The Pure-Vu EVS System
Ocuphire Pharma, Inc. Virtual Investor R&D Day
Aeglea BioTherapeutics KOL and Patient Caregiver Webinar on Arginase 1 Deficiency
Mitotech S.A. KOL Webinar on Visomitin®: A Potential Treatment For Dry Eye Disease
Gain Therapeutics R&D Day
Aptinyx Portfolio Review Event
Shield Therapeutics KOL Event on Iron Deficiency Treatment Innovation
Noema Pharma Trigeminal Neuralgia? You are not alone
LifeMD Hosts First Annual Investor & Analyst Day
IMV, Inc. Research & Development Day
Palatin Technologies KOL Webinar on Dry Eye Disease
Vicore Pharma R&D Day
PharmaMar Small Cell Lung Cancer: Today, until Tomorrow, US & EU
Seneca Therapeutics KOL Event on SVV & TEM 8
US Capital Markets Panel Discussion
Ultimovacs ASA: The Unmet Need and Treatment Landscape of Melanoma
LifeSci Partners: Addressing the risks and challenges of a stock price heading towards $1.00. Now What?
Vera Therapeutics KOL Webinar on BK Virus
Coherus Biosciences In-Person Analyst Day
AC Immune KOL Webinar on α-Synuclein as a Target in Neurodegenerative Diseases
Oramed KOL Webinar: The Need for Oral Insulin in Type 2 Diabetes
DocGo Fireside Chat with Carnival Corporation and Thomas Jefferson University
Trevi Therapeutics: Understanding the Seriousness of Chronic Cough in IPF Patients and Trevi’s Latest Data
Immunovant R&D Day
VBL Therapeutics In-Person KOL Event on Ovarian Cancer
Erasca, Inc. Investor Event
KOL Webinar on Evaxion’s Oncology Vaccine
Protalix Biotherapeutics: KOL Webinar on Protalix’s Positive Topline Results – Phase III BALANCE clinical trial of PRX-102
Molecular Templates: A Unique Approach to Immuno-Oncology for Solid Tumors
Fireside Chat on the Current Treatment of Acute Suicidal Ideation and Behavior and Discussion on The Market Potential for Seelos Therapeutics’ SLS-002 Program
LifeSci Partners x Medison Pharma: Edit Out The Mystery: Advances in Gene Editing
Viracta Therapeutics KOL Webinar on Nana-val for the Treatment of Epstein-Barr Virus-Positive (EBV+) Solid Tumors
Genenta Science: Expert Perspectives: Immuno Gene & Cell Therapy for the Treatment of Solid Tumors
Jasper Therapeutics: Hybrid KOL Event on Transforming the Field of Hematopoietic Stem Cell Therapies
IO Biotech: IO Biotech KOL Webinar Series – Part 1: A New Way to Kill Tumors? IO102-IO103 in Combination with Anti-PD-1 in Metastatic Melanoma
NextGen Healthcare Investor Event
Reviva to Host KOL Webinar on Antipsychotic Drug for Schizophrenia and other Neuropsychiatric Disorders
KOL Webinar on AcelRx’s Nafamostat Program
89bio KOL Webinar on Severe Hypertriglyceridemia (SHTG)
LifeSci Partners Immunology & Inflammation Symposium
KOL Webinar on BiomX’s BX004 Phage Therapy For Cystic Fibrosis Patients
Apexigen Investor Day
KOL Webinar on VYNE’s BET Inhibitor Platform
Captor Therapeutics R&D Day
Virtual KOL Event on TScan’s TCR-T Therapies
MindMed KOL Webinar on Substance Use Disorders & Withdrawal Management
KOL Event on Quotient’s MosaiQ™ Solution
Virtual KOL Breakfast on Valneva’s Chikungunya Vaccine Candidate (pre-BLA stage)
Arrowhead Pharmaceuticals Pulmonary R&D Day
KOL Event on Tenax’s TNX-201 (imatinib): A Potential Treatment for Pulmonary Arterial Hypertension
Aptose Biosciences KOL Data Call on HM43239 and Luxeptinib: Potential Treatment Candidates for AML
Fireside Chat with Nuvasive (NASDAQ: NUVA)
Kamada Virtual Analyst Day
NOXXON Pharma: KOL Webinar on GLORIA Top-Line Results of NOX-A12 & Radiotherapy Combination in First-Line Glioblastoma Presented at ASCO 2022
RYVU Therapeutics: KOL Event on RVU120: A First-in-Class CDK8/19i in Phase I Studies for Hematological Malignancies and Solid Tumors
Update on Sermonix’s Elaine Phase 2 Clinical Programs
Satsuma Pharmaceuticals: KOL Event on the Acute Treatment of Migraine, DHE and STS101
Cantargia R&D Day on nadunolimab
Mesoblast Key Opinion Leader Event Series for Investors & Analysts: Chronic Low Back Pain due to Degenerative Disc Disease
Recce Pharmaceuticals’ Expert KOL Webinar: How R327 is leading the way as a potential, robust solution to Sepsis and Superbugs
Please join us for the third episode in ASLAN Pharmaceuticals’ A4 webinar series, Aspects of Atopic Dermatitis and ASLAN004
PolyPid KOL Webinar on the Cost of Surgical Site Infection
Oncocyte: Expert Webinar on the role of DetermaIO and the Tumor Microenvironment in Clinical Practice
LifeSci Partners Genetic Medicines Symposium
Cidara Therapeutics: Research & Development Day
MediWound EscharEx Investor Breakfast
Science37: The Operating System that enables Hybrid/Agile Clinical Trials: Accelerating Timelines & Optimizing Cost Savings
A Novel Approach in Solid Tumors: Updates on Alpha Tau’s Recent and Upcoming Alpha DaRT Trials
ChromDex: The Transforming Benefits of Nicotinamide Riboside, Featuring Dr. Charles Brenner
LifeSci Platform
Founded in 2009, by Andrew McDonald PhD and Michael Rice, LifeSci is a platform of strategic healthcare advisory services in the areas of Investor Relations, Communications, Venture Investing, Partnering & Analytics, Capital Market Services, Executive Search and On-Demand Talent.
Comprehensive investor relations development and customized corporate communications advisory.
Investment baking services including equity/debt issuance, corporate finance and M&A advisory (member FINRA/SIPC).
Executive recruitment services operating globally and exclusively in the healthcare sector.
Early-stage investing division that partners with emerging healthcare companies during pre-public institutional rounds.
A global commercial strategy and transactions consultancy empowering corporate and business development.
Provides On Demand C-Level leaders who are available to guide clients through every stage of growth or change management.
Global communications and marketing agency focused in life science and medical technology.
First Though connects you with life science subject matter experts through our team of dedicated healthcare professionals and scientists.